A Randomized, Open-label, Phase 3 Study of MK-2870 vs Chemotherapy (Docetaxel or Pemetrexed) in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) with EGFR Mutations or Other Genomic Alterations

  • Arulananda, Surein (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date26/09/2325/09/28